US Study Reveals CP-GEP ' s Profound Impact on Stratifying Melanoma Patients for Long-Term Survival

ROTTERDAM, Netherlands and SAN DIEGO, Nov. 6, 2023 . SkylineDx, an innovative molecular diagnostics company, is pleased to announce the forthcoming presentation of an impactful poster by Dr M.E. Egger at the upcoming Society for Melanoma Research...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials